Itzíar Carrasco1,2, Mar Muñoz-Chapuli3, Sara Vigil-Vázquez4, David Aguilera-Alonso5,6,7, Concepción Hernández3, César Sánchez-Sánchez8, Cristina Oliver3, Mónica Riaza9, Marta Pareja10, Olga Sanz11, Beatriz Pérez-Seoane12, Juan López13, Elena Márquez14, Sara Domínguez-Rodríguez15, Alicia Hernanz-Lobo5,6,7, Juan Antonio De León-Luis6,3, Manuel Sánchez-Luna6,4, María Luisa Navarro5,6,7. 1. Paediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. itziiaarcg@gmail.com. 2. Facultad de Medicina Universidad Complutense de Madrid, Madrid, Spain. itziiaarcg@gmail.com. 3. Department of Obstetrics and Gynecology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 4. Department of Neonatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 5. Paediatric Infectious Disease Unit, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. 6. Facultad de Medicina Universidad Complutense de Madrid, Madrid, Spain. 7. Department of Paediatric Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 8. Department of Paediatric Gastroenterology Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain. 9. Department of Paediatrics, Hospital Universitario HM Montepríncipe, Madrid, Spain. 10. Department of Paediatrics, Hospital General de Albace, Castilla La Mancha, Spain. 11. Department of Obstetrics and Gynecology, Complejo Hospitalario de Navarra, Navarra, Spain. 12. Department of Neonatology, Hospital Universitario Infanta Sofía, Madrid, Spain. 13. Department of Paediatrics, Hospital Universitario Infanta Leonor, Madrid, Spain. 14. Department of Paediatrics, Hospital San Pedro de Alcántara, Cáceres, Spain. 15. Paediatric Infectious Diseases Unit, Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid, Spain.
Abstract
BACKGROUND: Knowledge about SARS-CoV-2 infection in pregnancy and newborns is scarce. The objective of this study is to analyse clinical and epidemiological characteristics of a cohort of women infected with SARS-CoV-2 during pregnancy and their newborns exposed to SARS-CoV-2 during gestation. METHODS: Multicentric observational study of Spanish hospitals from the GESNEO-COVD cohort, participants in RECLIP (Spanish Network of Paediatric Clinical Assays). Women with confirmed SARS-CoV-2 infection by PCR and/or serology during pregnancy, diagnosed and delivering during the period 15/03/2020-31/07/2020 were included. Epidemiological, clinical, and analytical data was collected. RESULTS: A total of 105 pregnant women with a median of 34.1 years old (IQR: 28.8-37.1) and 107 newborns were included. Globally, almost 65% of pregnant women had some COVID-19 symptoms and more than 43% were treated for SARS-COV-2. Overall, 30.8% of pregnant women had pneumonia and 5 (4.8%) women were admitted to the intensive care unit needing invasive mechanical ventilation. There was a rate of 36.2% of caesarean sections, which was associated with pneumonia during pregnancy (OR: 4.203, CI 95%: 1.473-11.995) and lower gestational age at delivery (OR: 0.724, CI 95%: 0.578-0.906). The prevalence of preterm birth was 20.6% and prematurity was associated with pneumonia during gestation (OR: 6.970, CI95%: 2.340-22.750) and having a positive SARS-CoV-2 PCR at delivery (OR: 6.520, CI95%: 1.840-31.790). All nasopharyngeal PCR in newborns were negative at birth and one positivized at 15 days of life. Two newborns died, one due to causes related to prematurity and another of unexpected sudden death during early skin-to-skin contact after delivery. CONCLUSIONS: Although vertical transmission has not been reported in this cohort, the prognosis of newborns could be worsened by SARS-CoV-2 infection during pregnancy as COVID-19 pneumonia increased the risk of caesarean section deliveries and preterm births.
BACKGROUND: Knowledge about SARS-CoV-2 infection in pregnancy and newborns is scarce. The objective of this study is to analyse clinical and epidemiological characteristics of a cohort of womeninfected with SARS-CoV-2 during pregnancy and their newborns exposed to SARS-CoV-2 during gestation. METHODS: Multicentric observational study of Spanish hospitals from the GESNEO-COVD cohort, participants in RECLIP (Spanish Network of Paediatric Clinical Assays). Women with confirmed SARS-CoV-2 infection by PCR and/or serology during pregnancy, diagnosed and delivering during the period 15/03/2020-31/07/2020 were included. Epidemiological, clinical, and analytical data was collected. RESULTS: A total of 105 pregnant women with a median of 34.1 years old (IQR: 28.8-37.1) and 107 newborns were included. Globally, almost 65% of pregnant women had some COVID-19 symptoms and more than 43% were treated for SARS-COV-2. Overall, 30.8% of pregnant women had pneumonia and 5 (4.8%) women were admitted to the intensive care unit needing invasive mechanical ventilation. There was a rate of 36.2% of caesarean sections, which was associated with pneumonia during pregnancy (OR: 4.203, CI 95%: 1.473-11.995) and lower gestational age at delivery (OR: 0.724, CI 95%: 0.578-0.906). The prevalence of preterm birth was 20.6% and prematurity was associated with pneumonia during gestation (OR: 6.970, CI95%: 2.340-22.750) and having a positive SARS-CoV-2 PCR at delivery (OR: 6.520, CI95%: 1.840-31.790). All nasopharyngeal PCR in newborns were negative at birth and one positivized at 15 days of life. Two newborns died, one due to causes related to prematurity and another of unexpected sudden death during early skin-to-skin contact after delivery. CONCLUSIONS: Although vertical transmission has not been reported in this cohort, the prognosis of newborns could be worsened by SARS-CoV-2 infection during pregnancy as COVID-19 pneumonia increased the risk of caesarean section deliveries and preterm births.
Authors: Gabriela N Algarroba; Patricia Rekawek; Sevan A Vahanian; Poonam Khullar; Thomas Palaia; Morgan R Peltier; Martin R Chavez; Anthony M Vintzileos Journal: Am J Obstet Gynecol Date: 2020-05-13 Impact factor: 8.661
Authors: Rafael San-Juan; Patricia Barbero; Mario Fernández-Ruiz; Francisco López-Medrano; Manuel Lizasoáin; Pilar Hernández-Jiménez; José Tiago Silva; María Ruiz-Ruigómez; Laura Corbella; Isabel Rodríguez-Goncer; María Dolores Folgueira; Antonio Lalueza; Emma Batllori; Inma Mejía; Laura Forcén; Carlos Lumbreras; Antonio García-Burguillo; Alberto Galindo; José María Aguado Journal: EClinicalMedicine Date: 2020-06-15
Authors: Maria Claudia Alzamora; Tania Paredes; David Caceres; Camille M Webb; Luis M Valdez; Mauricio La Rosa Journal: Am J Perinatol Date: 2020-04-18 Impact factor: 1.862
Authors: Patrick S Creisher; Jun Lei; Morgan L Sherer; Amanda Dziedzic; Anne E Jedlicka; Harish Narasimhan; Anna Chudnovets; Ariana D Campbell; Anguo Liu; Andrew Pekosz; Irina Burd; Sabra L Klein Journal: Front Virol Date: 2022-02-22
Authors: P Hidalgo-Lopezosa; A M Cubero-Luna; J Huertas-Marín; M Hidalgo-Maestre; A J De la Torre-González; M A Rodríguez-Borrego; P J López-Soto Journal: Women Birth Date: 2021-12-24 Impact factor: 3.172
Authors: Eva Morán Antolín; José Román Broullón Molanes; María Luisa de la Cruz Conty; María Begoña Encinas Pardilla; María Del Pilar Guadix Martín; José Antonio Sainz Bueno; Laura Forcén Acebal; Pilar Pintado Recarte; Ana Álvarez Bartolomé; Juan Pedro Martínez Cendán; Óscar Martínez-Pérez Journal: Viruses Date: 2021-11-22 Impact factor: 5.048
Authors: Sara Jones; Katie R Bradwell; Lauren E Chan; Courtney Olson-Chen; Jessica Tarleton; Kenneth J Wilkins; Qiuyuan Qin; Emily Groene Faherty; Yan Kwan Lau; Catherine Xie; Yu-Han Kao; Michael N Liebman; Federico Mariona; Anup Challa; Li Li; Sarah J Ratcliffe; Julie A McMurry; Melissa A Haendel; Rena C Patel; Elaine L Hill Journal: medRxiv Date: 2022-08-06
Authors: Elena Vazquez-Alejo; Laura Tarancon-Diez; Itzíar Carrasco; Sara Vigil-Vázquez; Mar Muñoz-Chapuli; Elena Rincón-López; Jesús Saavedra-Lozano; Mar Santos-Sebastián; David Aguilera-Alonso; Alicia Hernanz-Lobo; Begoña Santiago-García; Juan Antonio de León-Luis; Patricia Muñoz; Manuel Sánchez-Luna; María Luisa Navarro; Mª Ángeles Muñoz-Fernández Journal: Front Immunol Date: 2022-07-14 Impact factor: 8.786
Authors: María Martin-Vicente; Itziar Carrasco; María José Muñoz-Gomez; Alicia Hernanz Lobo; Vicente Mas; Sara Vigil-Vázquez; Mónica Vázquez; Angela Manzanares; Olga Cano; Roberto Alonso; Daniel Sepúlveda-Crespo; Laura Tarancón-Díez; María Ángeles Muñoz-Fernández; Mar Muñoz-Chapuli; Salvador Resino; Maria Luisa Navarro; Isidoro Martinez Journal: Birth Date: 2022-07-08 Impact factor: 3.081
Authors: Ernesto González-Mesa; Jesus Salvador Jiménez-López; Marta Blasco-Alonso; Jose Ramon Anderica-Herrero; Daniel Lubián-López Journal: J Clin Med Date: 2021-12-15 Impact factor: 4.241